0000899243-22-026586.txt : 20220722
0000899243-22-026586.hdr.sgml : 20220722
20220722170021
ACCESSION NUMBER: 0000899243-22-026586
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220720
FILED AS OF DATE: 20220722
DATE AS OF CHANGE: 20220722
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carey John F
CENTRAL INDEX KEY: 0001774272
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38891
FILM NUMBER: 221100433
MAIL ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
STREET 2: SUITE 302
CITY: ANDOVER
STATE: MA
ZIP: 01810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TransMedics Group, Inc.
CENTRAL INDEX KEY: 0001756262
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
BUSINESS PHONE: 9785520900
MAIL ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-20
0
0001756262
TransMedics Group, Inc.
TMDX
0001774272
Carey John F
C/O TRANSMEDICS GROUP, INC.
200 MINUTEMAN ROAD
ANDOVER
MA
01810
0
1
0
0
VP of Operations
Common Stock
2022-07-20
4
M
0
375
16.14
A
754
D
Common Stock
2022-07-20
4
M
0
1125
13.28
A
1879
D
Common Stock
2022-07-20
4
S
0
1500
34.57
D
379
D
Stock Option (Right to Buy)
16.14
2022-07-20
4
M
0
375
0.00
D
2030-02-27
Common Stock
375
6250
D
Stock Option (Right to Buy)
13.28
2022-07-20
4
M
0
1125
0.00
D
2032-02-22
Common Stock
1125
36875
D
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $34.50 to $34.71, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. As of the date of this report, the option remains subject to vesting with respect to 6,250 shares.
The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 22, 2022. As of the date of this report, the option remains subject to vesting with respect to 34,042 shares.
By: /s/ Stephen Gordon, as attorney-in-fact
2022-07-22